Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Apollo Hospital Ent
Join Channel
Consolidated Standalone

Apollo Hospital Ent.

₹5955.6 3.6 | 0.1%

Market Cap ₹85632 Cr.

Stock P/E 108.5

P/B 11.3

Current Price ₹5955.6

Book Value ₹ 525.6

Face Value 5

52W High ₹6871.3

Dividend Yield 0.25%

52W Low ₹ 4410.1

Edit Ratio

Apollo Hospital Ent. Research see more...

Overview Inc. Year: 1979Industry: Hospital & Healthcare Services

Apollo Hospitals Enterprise Limited is an India-based organisation, that is engaged in providing complete health facility offerings. The Company affords and sells pharma and well being products via a community of pharmacies. The predominant activities of the Company encompass the operation of multidisciplinary non-public hospitals, clinics and pharmacies. The Company operates via two segments: Healthcare and Retail Pharmacy. The Healthcare section represents hospitals and primarily medical institution-based pharmacies. The Retail Pharmacy section represents the commercial enterprise of procurement and distribution of pharmaceutical, FMCG and private label merchandise. The Company has approximately 10209 beds throughout about 71 Hospitals, 24118 pharmacies in 20 states and four union territories.

Read More..

Apollo Hospital Ent. Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Apollo Hospital Ent. Quarterly Results

#(Fig in Cr.) Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018
Net Sales 1625 1650 1813 1856 1863
Other Income 9 -4 3 8 5
Total Income 1634 1647 1816 1864 1869
Total Expenditure 1454 1477 1592 1635 1649
Operating Profit 179 170 224 229 219
Interest 58 55 59 64 62
Depreciation 63 65 66 68 73
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 59 50 99 98 84
Provision for Tax 10 15 28 30 24
Profit After Tax 48 35 71 67 60
Adjustments -48 -35 -71 -67 -60
Profit After Adjustments 0 0 0 0 0
Adjusted Earnings Per Share 3.5 2.5 5.1 4.8 4.3

Apollo Hospital Ent. Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 3318 3862 4593 5588 6301 7183 8337 9794 4654 6098 6525 7182
Other Income 31 22 45 40 48 14 14 18 21 47 152 12
Total Income 3349 3884 4638 5629 6349 7197 8351 9812 4675 6145 6676 7196
Total Expenditure 2764 3248 3915 4852 5549 6355 7320 8386 3945 4679 4843 6353
Operating Profit 585 636 723 777 800 842 1030 1426 730 1466 1833 842
Interest 73 87 83 134 200 240 268 426 340 244 239 240
Depreciation 109 129 158 201 241 272 300 482 421 363 367 272
Exceptional Income / Expenses 5 0 -15 -26 0 0 0 164 -9 -7 0 0
Profit Before Tax 408 420 467 417 359 330 463 682 -40 852 1228 331
Provision for Tax 99 89 121 83 74 97 160 212 -14 280 143 97
Profit After Tax 309 331 347 334 285 233 303 470 -26 573 1085 233
Adjustments 0 0 0 0 0 0 0 0 131 93 0 -233
Profit After Adjustments 309 331 347 334 285 233 303 470 105 665 1085 0
Adjusted Earnings Per Share 22.2 23.8 24.9 24 20.5 16.8 21.8 33.8 -1.8 39.8 75.4 16.7

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 7% -13% -2% 7%
Operating Profit CAGR 25% 9% 17% 12%
PAT CAGR 89% 32% 36% 13%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 34% 23% 38% 21%
ROE Average 17% 9% 9% 10%
ROCE Average 17% 12% 12% 12%

Apollo Hospital Ent. Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 2728 2965 3161 3316 3579 3693 3884 3988 5202 6111 6925
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 879 1005 1461 2003 2620 2547 2597 2500 1965 1908 1520
Other Non-Current Liabilities 243 332 402 530 938 1025 1164 2681 2065 2403 2594
Total Current Liabilities 505 555 796 989 750 1315 1633 1943 1521 1189 1243
Total Liabilities 4354 4857 5820 6838 7888 8581 9278 11112 10753 11611 12282
Fixed Assets 1692 1989 2428 3061 3600 3762 3970 6056 5038 5121 5078
Other Non-Current Assets 1221 1510 1696 2067 2543 2840 3305 2741 2678 3035 4054
Total Current Assets 1442 1358 1696 1710 1744 1980 2003 2315 3038 3455 3151
Total Assets 4354 4857 5820 6838 7888 8581 9278 11112 10753 11611 12282

Apollo Hospital Ent. Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 187 255 209 249 235 192 247 219 281 239 360
Cash Flow from Operating Activities 333 303 389 626 632 539 907 1096 915 1201 1225
Cash Flow from Investing Activities -631 -310 -681 -910 -804 -378 -776 -264 -765 -505 -589
Cash Flow from Financing Activities 367 -40 332 290 130 -106 -160 -771 -176 -577 -779
Net Cash Inflow / Outflow 69 -47 40 7 -43 54 -28 62 -25 119 -143
Closing Cash & Cash Equivalent 255 209 249 256 192 247 219 281 239 360 217

Apollo Hospital Ent. Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 22.22 23.77 24.91 24 20.5 16.76 21.75 33.78 -1.84 39.81 75.44
CEPS(Rs) 30.02 33.05 36.27 38.41 37.79 36.31 43.3 68.43 27.46 65.08 100.94
DPS(Rs) 5.5 5.75 5.75 6 6 5 6 6 3 11.75 15
Book NAV/Share(Rs) 196.05 213.1 227.21 238.31 257.25 265.48 278.99 286.52 361.72 424.94 481.56
Core EBITDA Margin(%) 16.68 15.9 14.76 13.18 11.94 11.53 12.19 14.38 15.23 23.28 25.77
EBIT Margin(%) 14.49 13.14 11.99 9.85 8.88 7.94 8.76 11.31 6.44 17.98 22.47
Pre Tax Margin(%) 12.3 10.88 10.18 7.46 5.7 4.6 5.55 6.97 -0.87 13.98 18.81
PAT Margin (%) 9.32 8.56 7.55 5.98 4.53 3.25 3.63 4.8 -0.57 9.39 16.63
Cash Profit Margin (%) 12.59 11.91 10.99 9.56 8.34 7.03 7.23 9.72 8.49 15.35 22.25
ROA(%) 7.88 7.18 6.49 5.28 3.87 2.83 3.39 4.61 -0.24 5.12 9.08
ROE(%) 12.26 11.62 11.32 10.31 8.27 6.41 7.99 11.95 -0.57 10.12 16.64
ROCE(%) 14.42 13.11 12.39 10.49 9.32 8.76 10.58 15.53 4.1 14.04 17.43
Receivable days 42.93 42.3 40.45 35.78 35.04 35.91 36.32 34.94 85.1 60.7 45.99
Inventory Days 21.35 22.23 23.74 23.31 23.86 24.93 24.08 23.64 35.99 10.69 6.86
Payable days 36.85 38.75 42.83 45.95 43.04 41.55 42.18 44.51 235.4 142.16 126.12
PER(x) 37.52 38.53 54.81 55.18 56.92 63.4 56.13 33.69 0 113.44 57.12
Price/Book(x) 4.25 4.3 6.01 5.56 4.54 4 4.38 3.97 8.03 10.63 8.95
Dividend Yield(%) 0.66 0.63 0.42 0.45 0.51 0.47 0.49 0.53 0.1 0.26 0.35
EV/Net Sales(x) 3.71 3.53 4.45 3.67 2.97 2.43 2.39 1.9 9.37 10.89 9.72
EV/Core EBITDA(x) 21.06 21.39 28.24 26.41 23.4 20.75 19.37 13.08 59.75 45.29 34.59
Net Sales Growth(%) 18.49 16.39 18.93 21.68 12.76 13.99 16.06 17.49 -52.48 31.04 6.99
EBIT Growth(%) 19.82 5.54 8.55 0.01 1.57 1.97 28.09 51.7 -72.97 265.92 33.75
PAT Growth(%) 33.82 6.99 4.8 -3.65 -14.61 -18.22 29.85 55.28 -105.61 2268.56 89.48
EPS Growth(%) 29.34 6.99 4.8 -3.65 -14.61 -18.22 29.78 55.28 -105.44 2268.54 89.48
Debt/Equity(x) 0.35 0.36 0.53 0.71 0.77 0.81 0.83 0.79 0.44 0.33 0.25
Current Ratio(x) 2.86 2.45 2.13 1.73 2.32 1.51 1.23 1.19 2 2.91 2.53
Quick Ratio(x) 2.45 1.97 1.71 1.34 1.74 1.1 0.88 0.83 1.86 2.78 2.46
Interest Cover(x) 6.62 5.83 6.61 4.12 2.79 2.37 2.73 2.6 0.88 4.49 6.14
Total Debt/Mcap(x) 0.08 0.08 0.09 0.13 0.17 0.2 0.19 0.2 0.05 0.03 0.03

Apollo Hospital Ent. Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 29.33 29.33 29.33 29.33 29.33 29.33 29.33 29.33 29.33 29.33
FII 52.41 50.81 48.48 49.09 47.94 46.96 47.93 46.15 46.25 45.63
DII 12.39 13.16 15.86 15.51 16.78 17.99 17.24 18.83 19.1 19.77
Public 5.8 6.64 6.32 6.07 5.94 5.71 5.5 5.69 5.32 5.26
Others 0.06 0.06 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 36% CAGR over last 5 years
  • Debtor days have improved from 142.16 to 126.12days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 29.33%.
  • Company has a low return on equity of 9% over the last 3 years.
  • Stock is trading at 11.3 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Apollo Hospital Ent. News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!